EUVIMEDEUVIMED entdecken
Open Access

P2X 7 receptors exhibit at least three modes of allosteric antagonism

Adam C Oken iD, Ismayn A Ditter iD, Nicolas E Lisi iD, Ipsita Krishnamurthy iD, Michael H Godsey iD, Steven E Mansoor iD

Science Advances · 2024

DOI: 10.1126/sciadv.ado5084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Adam C Oken und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, OR 97239, USA. Hauptthemen laut MEDLINE: Cryoelectron Microscopy, Purinergic P2X Receptor Antagonists, Receptors, Purinergic P2X7. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

P2X receptors are trimeric ion channels activated by adenosine triphosphate (ATP) that contribute to pathophysiological processes ranging from asthma to neuropathic pain and neurodegeneration. A number of small-molecule antagonists have been identified for these important pharmaceutical targets. However, the molecular pharmacology of P2X receptors is poorly understood because of the chemically disparate nature of antagonists and their differential actions on the seven constituent subtypes. Here, we report high-resolution cryo–electron microscopy structures of the homomeric rat P2X 7 receptor bound to five previously known small-molecule allosteric antagonists and a sixth antagonist that we identify. Our structural, biophysical, and electrophysiological data define the molecular determinants of allosteric antagonism in this pharmacologically relevant receptor, revealing three distinct classes of antagonists that we call shallow, deep, and starfish. Starfish binders, exemplified by the previously unidentified antagonist methyl blue, represent a unique class of inhibitors with distinct functional properties that could be exploited to develop potent P2X 7 ligands with substantial clinical impact.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cryoelectron MicroscopyPurinergic P2X Receptor AntagonistsReceptors, Purinergic P2X7AnimalsHumansRatsAdenosine TriphosphateAllosteric RegulationLigandsModels, MolecularProtein BindingFemaleSf9 CellsOocytesXenopus laevis

Substanzen

Adenosine TriphosphateLigandsPurinergic P2X Receptor AntagonistsReceptors, Purinergic P2X7

Autor:innen und Institutionen

  • Department of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, OR 97239, USA.
  • Division of Cardiovascular Medicine, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR 97239, USA.

ORCID-Profile: Adam C Oken, Ismayn A Ditter, Nicolas E Lisi, Ipsita Krishnamurthy, Michael H Godsey, Steven E Mansoor

Förderung

  • NIGMS NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Oken, A. C., Ditter, I. A., Lisi, N. E., Krishnamurthy, I., Godsey, M. H., & Mansoor, S. E. (2024). P2X 7 receptors exhibit at least three modes of allosteric antagonism. Science Advances. https://doi.org/10.1126/sciadv.ado5084

Vancouver

Oken AC, Ditter IA, Lisi NE, Krishnamurthy I, Godsey MH, Mansoor SE. P2X 7 receptors exhibit at least three modes of allosteric antagonism. Science Advances. 2024. doi:10.1126/sciadv.ado5084

BibTeX
@article{Oken2024,
  author = {Oken, Adam C and Ditter, Ismayn A and Lisi, Nicolas E and Krishnamurthy, Ipsita and Godsey, Michael H and Mansoor, Steven E},
  title = {P2X 7 receptors exhibit at least three modes of allosteric antagonism},
  journal = {Science Advances},
  year = {2024},
  doi = {10.1126/sciadv.ado5084}
}
Kostenlos starten →